SciELO - Scientific Electronic Library Online

 
vol.11 número1Sticholisina II encapsulada en liposomas potencia una respuesta de linfocitos T citotóxicos específica al antígenoAutoanticuerpos para diagnóstico y pronóstico en artritis reumatoide: inmunoensayo cubano con péptido citrulinado del fibrinógeno índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Anales de la Academia de Ciencias de Cuba

versión On-line ISSN 2304-0106

Resumen

SAAVEDRA HERNANDEZ, Danay et al. Immunosenescence markers: relationships with diagnosed with lung cancer. Anales de la ACC [online]. 2021, vol.11, n.1, e826.  Epub 30-Ago-2021. ISSN 2304-0106.

Introduction:

The changes that occur in the immune system with aging are commonly termed immunosenescence. Objective: To investigate the effect of age and gender on lymphocyte populations in healthy humans and patients diagnosed with lung cancer, to evaluate immunosenescence biomarkers to predict clinical efficacy of CIMAvax-EGF cancer vaccine and to evaluate whether the administration of a thymic factor influences the distribution of immunosenescence biomarkers and populations of the immune system.

Methods:

an evaluation was made of immunosenescence markers in healthy people of all ages and in patients diagnosed with non-small cell lung cancer (NSCLC).

Results:

In the healthy volunteers, CD4+ T lymphocytes and B cells decreased with age, while terminally differentiated T cells increased. There were different patterns of immunosenescence with respect to sex. The treatment of elderly patients diagnosed with recurrent respiratory infections with the thymic factor Biomodulina T (BT) induced the expansion of naïve CD4+ T cells, CD8+ stem cell-like memory (SCM) and CD4+ recent thymic emigrants (RTE), whereas CD4+ and CD8+ T cells expressing PD1 decreased after the treatment with BT. Moreover, BT did not increase CD4+ Tregs. The absolute count of CD19+ and the CD4/CD8 ratio were significantly lower in NSCLC patients than in age-paired controls, while IL-6 serum concentration and terminally differentiated T cells increased in NSCLC patients treated with platinum-based chemotherapy. Vaccinated patients with frequency <24 % of CD8 + CD28− T cells, >40 % of CD4 T cells and CD4/CD8 ratio higher than two at the beginning of immunotherapy achieved a 20-month increase in median survival regarding control patients. This study showed for the first time the pattern of immunosenescence markers in the Cuban population and suggests that these markers can be modified by age, sex, cancer and platinum-based chemotherapy.

Palabras clave : immunosenescence; T cells; late-stage differentiated T cells; Biomodulina T; non-small cell lung cancer; CIMAvax-EGF.

        · resumen en Español     · texto en Español     · Español ( pdf )